ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,834 Cr | ₹1,611 Cr | ₹1,521 Cr | ₹1,411 Cr | ₹1,260 Cr |
What is the latest Total Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,834 Cr |
| Mar2025 | ₹1,611 Cr |
| Mar2024 | ₹1,521 Cr |
| Mar2023 | ₹1,411 Cr |
| Mar2022 | ₹1,260 Cr |
How is Total Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,834 Cr | 13.82 | |
| Mar2025 | ₹1,611 Cr | 5.91 | |
| Mar2024 | ₹1,521 Cr | 7.85 | |
| Mar2023 | ₹1,411 Cr | 11.93 | |
| Mar2022 | ₹1,260 Cr | - | |
Compare Total Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,296.7 Cr | -8.9% | -10.7% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -8.9% |
-10.7% |
-10% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses